Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04698213
Title Avelumab Plus Intermittent Axitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma (TIDE-A)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Consorzio Oncotech
Indications

renal cell carcinoma

Therapies

Avelumab + Axitinib

Age Groups: senior | adult
Covered Countries ITA


No variant requirements are available.